Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Adenosine and ischemic preconditioning.

B T Liang1, K A Jacobson

  • 1Department of Medicine, Cardiovascular Division, University of Pennsylvania Medical Center, Philadelphia, PA 19104, USA. liangb@mail.med.upenn.edu

Current Pharmaceutical Design
|December 23, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Purinoceptors in the Central Nervous System.

Drug development research·2024
Same author

The Anti-Cancer Effect of A<sub>3</sub> Adenosine Receptor Agonists: A Novel, Targeted Therapy.

Immunology, endocrine & metabolic agents in medicinal chemistry·2021
Same author

EFFECT OF NEW PYRIDOXAL PHOSPHATE ARYLAZO DERIVATIVES ON THE ECTO-ATPase ACTIVITY IN GUINEA PIG TISSUES.

Pharmaceutical chemistry journal·2019
Same author

Identification of A3 adenosine receptor agonists as novel non-narcotic analgesics.

British journal of pharmacology·2016
Same author

A PROSTHETIC GROUP FOR THE RAPID INTRODUCTION OF FLUORINE INTO PEPTIDES AND FUNCTIONALIZED DRUGS.

Journal of fluorine chemistry·2015
Same author

SYNTHESIS AND BIOLOGICAL ACTIVITY OF NOVEL 2-THIO DERIVATIVES OF ATP.

Nucleosides & nucleotides·2014
Same journal

Overcoming Physiological Barriers in Brain Tumor Therapy: Advances in Nanomedicine, Ultramolecular Pharmaceuticals, and Targeted Drug Delivery.

Current pharmaceutical design·2026
Same journal

Breathing Life into Research: The Transformative Potential of Lung-on-a-Chip Technology.

Current pharmaceutical design·2026
Same journal

Cross-Tissue Transcriptome-Wide Association Study Prioritizes Candidate Genes and Compound-Associated Signatures for Osteoarthritis.

Current pharmaceutical design·2026
Same journal

Emerging Role of AI in Gastroenterology and Hepatology: Revolutionizing Medical Device-Assisted Diagnosis.

Current pharmaceutical design·2026
Same journal

Nanostructured Lipid Carriers in Drug Targeting: Characterization, Patents, and Recent Innovations.

Current pharmaceutical design·2026
Same journal

Corrigendum to: miRNA in Diagnosis and Therapeutics of Tuberculosis: Importance in Latent and Brain Associated Pathologies.

Current pharmaceutical design·2026
See all related articles

Adenosine offers significant cardioprotection during myocardial ischemia. Recent research clarifies adenosine receptor mechanisms, revealing its anti-ischemic effects and potential cardiovascular applications.

Area of Science:

  • Cardiovascular Pharmacology
  • Molecular Cardiology
  • Biochemistry

Background:

  • Adenosine is released during myocardial ischemia and exhibits cardioprotective properties.
  • The precise mechanisms underlying adenosine's anti-ischemic effects are not fully understood.
  • Advances in adenosine receptor ligand chemistry offer new insights into cardiovascular functions.

Purpose of the Study:

  • To review the role of adenosine receptors in mediating cardioprotection during ischemia.
  • To discuss novel adenosine receptor ligands and their pharmacology.
  • To explore downstream signaling pathways and potential clinical applications.

Main Methods:

  • Review of recent literature on adenosine receptor pharmacology and cardiac signaling.
  • Analysis of studies utilizing model systems for cardiac adenosine actions.

Related Experiment Videos

  • Focus on molecular mechanisms linking receptor activation to cardioprotection.

    • Main Results:

    • Adenosine receptor subtypes play a crucial role in mediating the anti-ischemic effects of adenosine.
    • New ligands provide valuable tools for studying adenosine receptor function.
    • Elucidation of signaling cascades from receptor activation to cardioprotective outcomes.

    Conclusions:

    • Adenosine receptor signaling is a key mechanism for myocardial protection.
    • Understanding these pathways opens avenues for novel therapeutic strategies in cardiovascular disorders.
    • Further research into adenosine receptor modulation holds promise for treating ischemic heart conditions.